ONCOLOGÍA CLÍNICA
Universidad Complutense de Madrid
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Universidad Complutense de Madrid (3)
2018
-
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)
Oncologist, Vol. 23, Núm. 4, pp. 422-432
2017
-
Functional proteomics outlines the complexity of breast cancer molecular subtypes
Scientific Reports, Vol. 7, Núm. 1
-
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology, Vol. 18, Núm. 12, pp. 1688-1700